![Matthew Emmens](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Emmens
Keine laufenden Positionen mehr
Profil
Matthew W. Emmens ist ein amerikanischer Geschäftsmann, der an der Spitze von 6 verschiedenen Unternehmen stand und im Vorstand von Bristol Myers Squibb Co. ist. In seiner bisherigen Laufbahn hatte er die Position eines Direktors bei Vertex Pharmaceuticals, Inc. inne, Präsident & Direktor bei Merck KGaA und Präsident & Chief Executive Officer für EMD Pharmaceuticals, Inc. (eine Tochtergesellschaft der Merck KGaA), Non-Executive Chairman bei Shire Plc, Chief Executive Officer bei Shire Plc, President & Chief Executive Officer von Astra Merck, Inc. und Director-Investor Relations bei New River Pharmaceuticals, Inc. Herr Emmens erwarb einen Bachelor-Abschluss an der Fairleigh Dickinson University.
Ehemalige bekannte Positionen von Matthew Emmens
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Direktor/Vorstandsmitglied | 04.05.2021 |
| SHIRE | Vorsitzender | 29.04.2014 |
| INCYTE CORPORATION | Direktor/Vorstandsmitglied | 04.02.2009 |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Vorstandsvorsitzender | 23.05.2008 |
Shire Acquisition, Inc.
 Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Direktor/Vorstandsmitglied | 12.03.2008 |
Ausbildung von Matthew Emmens
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Shire Acquisition, Inc.
Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops novel products | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Sells pharmaceuticals products | Health Technology |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
